Nonmelanoma Skin Cancer Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers
Conditions: Adenoid Cystic Carcinoma; Adnexal Carcinoma; Apocrine Carcinoma; Eccrine Porocarcinoma; Extraocular Cutaneous Sebaceous Carcinoma; Hidradenocarcinoma; Keratoacanthoma; Malignant Sweat Gland Neoplasm; Merkel Cell Carcinoma; Microcystic Adnexal Carcinoma; NK-Cell Lymphoma, Unclassifiable; Non-Melanomatous Lesion; Paget Disease; Papillary Adenocarcinoma; Primary Cutaneous Mucinous Carcinoma; Refractory Anaplastic Large Cell Lymphoma; Refractory Cutaneous T-Cell Non-Hodgkin Lymphoma; Refractory Mature T-Cell and NK-Cell Non-Hodgkin...
Source: ClinicalTrials.gov - November 30, 2016 Category: Research Source Type: clinical trials

Laser Assisted Drug Delivery in the Treatment of Superficial Non Melanoma Skin Cancer: a Randomized Controlled Trial
Conditions: Bowen's Disease; Superficial Basal Cell Carcinoma Interventions: Device: full ablative CO2 laser; Device: fractional ablative CO2 laser; Drug: MAL; Device: LED lamp; Drug: lidocaine hydrochloride 2% with epinephrine Sponsor: University Hospital, Ghent Recruiting - verified January 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 21, 2016 Category: Research Source Type: clinical trials